VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 64 filers reported holding VENTYX BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $352,266 | -95.2% | 10,143 | -95.5% | 0.00% | -100.0% |
| Q2 2023 | $7,381,640 | +218.1% | 225,050 | +224.9% | 0.01% | +150.0% |
| Q1 2023 | $2,320,277 | +1339.1% | 69,262 | +1308.6% | 0.00% | – |
| Q4 2022 | $161,228 | +91.9% | 4,917 | +104.2% | 0.00% | – |
| Q3 2022 | $84,000 | -94.5% | 2,408 | -98.1% | 0.00% | -100.0% |
| Q2 2022 | $1,523,000 | +25283.3% | 124,512 | +30492.6% | 0.00% | – |
| Q1 2022 | $6,000 | -89.3% | 407 | -85.6% | 0.00% | – |
| Q4 2021 | $56,000 | – | 2,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |